SEC Tracker
Get the app

Priveterra Acquisition AEON

Priveterra Acquisition: proxy statement

Form
DEF 14A
Filed
Period
Importance
Routine
Document
DEF 14A

Not explained yet; the original is on EDGAR.

Proxy statement

View on EDGAR

Open in the app

Get an email when Priveterra Acquisition files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. GT Biopharma GTBP public float $9M, Jun 30, 2025
  2. TherapeuticsMD TXMD public float $9M, Jun 30, 2025
  3. Oncotelic Therapeutics OTLC public float $9M, Jun 30, 2025
  4. Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025
  5. Traws Pharma ONTX public float $10M, Jun 30, 2025